HIV Management Guide for Clinical Care and ARV Guidelines

HIV Management Guide for Clinical Care and ARV Guidelines

Management

Diagnosis

The   diagnosis   of   VZV   infection   is   usually   clinical, however VZV PCR of vesicular fluid should be used for confirmation.  VZV IgM is detected in acute chickenpox and in about 70% of people with HZ, whereas VZV IgG cannot differentiate acute and past infection or prior immunisation. (35). 

Management, prevention and vaccination

Antiviral treatment for primary VZV infection is indicated in neonates, children and adults with HIV infection or other immunodefiencies, as well  those with severe disease. These include oral valaciclovir, famiciclovir or aciclovir (dosages and durations provided in Table 3). Treatment should begin within 24–48 hours of onset, however in immunocompromised patients (including people living with …

Management, prevention and vaccination Read More »

Herpes simplex virus

Serological studies estimate approximately 67% and 16% of the global population are living with Herpes Simplex Virus (HSV)-1 and -2, respectively. (6, 7). Both HSV-1 and -2 are typically acquired in childhood or early adulthood, primarily through vertical or sexual transmission, and are never cleared. (8) In the immunocompetent population, HSV infection is typically latent …

Herpes simplex virus Read More »

Diagnosis

The diagnosis of mucocutaneous HSV may be made on clinical grounds alone in the majority of cases. Vesicular fluid should be swabbed to confirm the presence of HSV using polymerase chain reaction (PCR) or nucleic acid amplification testing (NAAT), and exclude other alternate or concurrent viral pathogens (including varicella, discussed below) as well as bacterial …

Diagnosis Read More »

Management and Prevention

There is no difference in management between HSV-1 and HSV-2 infection. Few randomised, controlled trials have been performed in PLWHIV. Aciclovir, famciclovir and valaciclovir have all been shown to be safe and effective as both intermittent and continuous therapy for HSV-2 clinical and subclinical infection in HIV-positive individuals. (21)   In the majority of situations, mucocutaneous …

Management and Prevention Read More »

Human papilloma virus (warts)

In general, human papillomavirus (HPV) infections are considered benign. However, HPV subtypes 16, 18 and several others have oncogenic potential and have been shown to be associated with malignant transformation. (51) Neoplastic transformation to squamous cell carcinoma can occur  in association with HPV infection of the skin, oral mucosa cervix, vulva, penis and anogenital mucosa. Precursor …

Human papilloma virus (warts) Read More »

Diagnosis

The   diagnosis   of   HPV   warts   is   usually   clinical.  A biopsy may be  helpful in establishing a diagnosis, particularly in verrucal lesions unresponsive to therapy or when warts have unusual features, such as hyperpigmentation, ulceration, rapid growth or excessive bleeding. (59) At mucosal sites, premalignant lesions (e.g. penile or vulval HSIL) caused by HPV can   be …

Diagnosis Read More »

Management and prevention

Treatment of cutaneous and anogenital warts is directed on the alleviation of signs and symptoms with traditional treatment modalities focusing on the destruction of infected tissue.  First-line treatments for warts include cryotherapy or keratolytics such as topical salicylic acid-based preparations, either separately or in combination. (53) Refractory warts may require referral for off-label therapies, such …

Management and prevention Read More »

Molluscum contagiosum

Molluscum contagiosum (MC) virus is a poxvirus that causes a localised cutaneous infection most often seen in children. MC is spread by direct skin-to-skin contact, occurring anywhere on the body except the palms of the hands and soles of the feet. In people living with HIV, prevalence of MC has been reported to be as …

Molluscum contagiosum Read More »

Clinical presentation

Clinical presentation  Classically, MC presents as dome shaped, flesh-coloured 2-6 mm papules with central umbilication (70)  In PLWHIV who are virally suppressed, MC lesions may not differ clinically to people without HIV, whereas in advanced HIV can be more numerous, larger and verrucous in morphology. (71, 72) .  

Scroll to Top